788:HKEXChina Tower Corp. Ltd. Class H Analysis
Data as of 2026-05-13 - not real-time
€13.52
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Coupang (788.F) is trading at the exact support level of €13.52, well below its 20‑day (≈€16.66) and 50‑day (≈€16.60) simple moving averages and far above the DCF‑derived fair value of €2.97. The stock is in an oversold zone (RSI ≈ 24.8) but the MACD remains bearish, signaling mixed short‑term momentum. Volume is increasing, yet volatility is extreme at ~56% over the past 30 days, and the beta of 0.54 suggests limited market‑wide price correlation.
Fundamentally, revenue is growing modestly at 7.5% YoY, but operating margins are negative (‑2.8%) and profit margins are in the loss territory (‑0.47%). Debt‑to‑equity stands at a lofty 137%, cash reserves barely cover the debt, and the price‑to‑book ratio of 7.3 is high for a company still posting losses. No dividend is paid, and the market sentiment index shows “Extreme Greed,” which may be disconnected from the underlying financial health.
Fundamentally, revenue is growing modestly at 7.5% YoY, but operating margins are negative (‑2.8%) and profit margins are in the loss territory (‑0.47%). Debt‑to‑equity stands at a lofty 137%, cash reserves barely cover the debt, and the price‑to‑book ratio of 7.3 is high for a company still posting losses. No dividend is paid, and the market sentiment index shows “Extreme Greed,” which may be disconnected from the underlying financial health.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price sitting at a strong support level
- Oversold RSI indicating potential bounce
- Bearish MACD and high volatility raising downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Continued operating losses and negative profit margin
- Elevated debt‑to‑equity ratio limiting financial flexibility
- Market price far exceeds DCF fair value
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Significant overvaluation relative to intrinsic value
- Unclear path to sustainable profitability
- High leverage and exposure to multiple regulatory environments
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin-0.47%
ROE-3.99%
ROA0.38%
Debt/Equity137.30
P/B Ratio7.3
Op. Cash Flow€1.6B
Free Cash Flow€242.3M
Technical Analysis
TrendNeutral
RSI24.8
Support€13.52
Resistance€18.67
MA 20€16.66
MA 50€16.60
MA 200€21.28
MACDBearish
VolumeIncreasing
Fear & Greed Index89.38
Valuation
Fair Value€2.97
GradeOvervalued
TypeValue
Risk Assessment
Beta0.54
Volatility55.75%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.